Results of morphological diagnosis of the aetiology of the diffuse lung disease syndrome.

Authors

  • I. V. Liskina State Institution “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky National Academy of Medical Sciences of Ukraine ”, Kyiv, Ukraine https://orcid.org/0000-0001-8879-2345
  • N. S. Opanasenko State Institution “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky National Academy of Medical Sciences of Ukraine ”, Kyiv, Ukraine https://orcid.org/0000-0003-4071-2005
  • S. M. Shalagay State Institution “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky National Academy of Medical Sciences of Ukraine ”, Kyiv, Ukraine https://orcid.org/0000-0003-4071-2005
  • L. M. Zagaba State Institution “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky National Academy of Medical Sciences of Ukraine ”, Kyiv, Ukraine https://orcid.org/0000-0002-2593-8893
  • V. I. Lysenko State Institution “National Institute of Phthisiology and Pulmonology named after F.G. Yanovsky National Academy of Medical Sciences of Ukraine ”, Kyiv, Ukraine https://orcid.org/0000-0003-3920-7466

DOI:

https://doi.org/10.26641/1997-9665.2019.3.70-78

Keywords:

dissemination, diffuse lung deseases, lung biopsy, morphological diagnosis

Abstract

Background. Diffuse Pulmonary diseases (DZL) is a heterogeneous group of diseases united on the basis of the characteristic radiological syndrome of pulmonary dissemination, which is manifested by widespread changes in both lungs of nodular, reticulate or mixed character with nonspecific clinical and altered pathological changes. Objective. To present the results of morphological diagnostics of the pathological process in the syndrome of pulmonary dissemination and to compare them with the final clinical diagnoses when applying different methods of biopsy sampling. Methods. 216 lung biopsies were selected for morphological diagnosis, followed by histological examination in 210 patients. Patients were divided into 4 groups depending on the method of obtaining biopsy material for histological examination (video assisted, open and transbronchial lung biopsy). Results. Most patients were with sarcoidosis 81 (37.5 ± 3.3)%metastatic lung damage was diagnosed for 36 (16.7 ± 2.5)% cases. Other diseases (various forms of fibrotic alveolitis, alveolar proteinosis, histiocytosis, diffuse pulmonary ossification, etc.) 25 (11.6 ± 2.2)% and pulmonary tuberculosis – 24 (11.1 ± 2.1) % cases. Conclusion. Prevalent patients were diagnosed with "disseminated process in lungs of unknown etiology" – 121 (57,6 ± 3,4)% of patients and "diffuse process in lungs in combination with syndrome of intrathoracic lymphadenopathy" – 41 (19,5 ± 2,7)% patient. According to the histological examination, sarcoidosis was the most common in 81 (37.5 ± 3.3)% of cases and metastatic lung injury was 36 (16.7 ± 2.5)%; Morphological examination of the pulmonary tissue in the case of pulmonary dissemination syndrome reveals numerous diseases of different etiology; or "narrows" the spectrum of pathology in the differential diagnosis of a particular disease.

References

  1. Kornum JB, Christensen S, Grijota M, Pedersen L, Wogelius P, Beiderbeck A,Sørensen HT. The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study. BMC Pulm Med. 2008;8:24. doi: 10.1186/1471-2466-8-24. PubMed PMID: 18983653; PubMed Central PMCID: PMC2642752.
  2. Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax. 2011;66(6):462-7. doi: 10.1136/thx.2010.148031. Epub 2011 Apr 27. PubMed PMID: 21525528.
  3. Lynnyk MI, Feshchenko YI. Porivnialni dani pro rozpovsiudzhenist khvorob orhaniv dykhannia i medychnu dopomohu khvorym na khvoroby pulmonolohichnoho ta alerholohichnoho profiliu v Ukraini za 2008–2009 rr. Kyiv: NIFP NAMNU; 2010. 48p. Ukrainian.
  4. Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010 Mar;35(3):496-504. doi: 10.1183/09031936.00077309. PubMed PMID: 20190329.
  5. Collard HR, Chen SY, Yeh WS, Li Q, Lee YC, Wang A, Raghu G. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older. Ann Am Thorac Soc. 2015 Jul;12(7):981-7. doi: 10.1513/AnnalsATS.201412-553OC. PubMed PMID: 25923447.
  6. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48. doi: 10.1164/rccm.201308-1483ST. PubMed PMID: 24032382; PubMed Central PMCID: PMC5803655.
  7. Avdeeva OE, Avdeev SN. Ydyopatycheskyi fybrozyruiushchyi alveolyt: sovremennye podkhody k dyahnostyke i terapii [Idiopathic fibrous alveolitis, modern approaches to diagnosis and treatment]. Consilium medicum. 2002.4;195-201. Russian.
  8. Nicholson AG, Addis BJ, Bharucha H, Clelland CA, Corrin B, Gibbs AR, Hasleton PS, Kerr KM, Ibrahim NB, Stewart S, Wallace WA, Wells AU. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004 Jun;59(6):500-5. PubMed PMID: 15170033; PubMed Central PMCID: PMC1747021.
  9. Kamenieva MYu, Trofymov VI, Tyshkov AV. Informatyvnist spirometrii v diahnostytsi porushen mekhaniky dykhannia u khvorykh z interstytsialnymy zakhvoriuvanniamy lehen [Spirometry informativeness in the diagnosis of respiratory mechanics disorders in patients with interstitial lung diseases]. Biuleten fiziolohii i patolohii dykhannia. 2015;55:8-14. Russian.
  10. Havrysiuk VK, Monoharova NE, Merenkova EA, Leshchenko SY. Khirurhichna biopsiia leheni - zolotyi standart diahnostyky idiopatychnykh interstytsialnykh pnevmonii? [Surgical lung biopsy is the gold standard for diagnosing idiopathic interstitial pneumonia?] Ukr. pulmonol. zhurnal. 2010;3:14-18. Russian.
  11. Lyskyna IV, Sylchenko VP, Irkyn IV, Zahaba LM. Dyfuzni parenkhimatozni zakhvoriuvannia leheniv: mozhlyvosti biopsii leheniv v veryfikatsii diahnozu, vyznachenni taktyky likuvannia i prohnozu [Diffuse parenchymal lung diseases: possibilities of lung biopsy in verifying the diagnosis, determining treatment tactics and prognosis]. Ukr. pulmonol. zhurnal. 2008;4:43-46. Ukrainian.
  12. Havrysiuk VK. Redkye interstitsyalnye zabolevanyia lehkykh [Rare interstitial lung disease]. Kyiv:Veles; 2012.148 p. Russian.
  13. Ponomareva E, Rebrov AP, Landfang SV, Roschina AA. [Diagnosis difficulties in disseminated lung processes]. Clinical Medicine2013;91(7):61-64. Russian.
  14. Shim HS, Park MS, Park IK. Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int. 2010 May;60(5):373-7. doi: 10.1111/j.1440-1827.2010.02528.x. PubMed PMID: 20518887.
  15. Ovchynnikov AA. Diagnostic and therapeutic possibilities of modern bronchoscopy. Russian Medical Journal. 2000;12;515-522. Russian.
  16. Lapach SN, Chubenko AV, Babych PN. [Statistical methods in biomedical research using Excel]. Kyiv: Morion; 2000. 320 p. Russian.

Downloads

How to Cite

Liskina, I. V., Opanasenko, N. S., Shalagay, S. M., Zagaba, L. M., & Lysenko, V. I. (2019). Results of morphological diagnosis of the aetiology of the diffuse lung disease syndrome. Морфологія / Morphologia / Morfologìâ, 13(3), 70–78. https://doi.org/10.26641/1997-9665.2019.3.70-78

Issue

Vol. 13 No. 3 (2019)

Section

Статті

License

Copyright (c) 2019 Morphologia

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

 The authors reserve the right to authorship of their work and transfer to the Journal the right to the first publication of this work under the terms of a license Creative commons Attribution 4.0 International (CC BY 4.0), which allows other people to freely distribute the published work with a mandatory reference to the authors of the original work and the first publication of the work in this journal.
        By submitting a manuscript to the editorial office of the Journal ‘Morphologia’ authors agree to transfer the rights to protect and use the manuscript (all supplemental materials, particularly protected objects such as photos, drawings, diagrams, tables, etc.), including the reproduction in the press and distribution via the Internet; translation of the manuscript into any language; export and import of journal copies with the Authors’ article in order to make it available for public. Authors convey the rights mentioned above to the editorial office without any temporal or territorial limitation all over the world. 
        The Authors guarantee that they have the exclusive rights to use the material transferred to editorial office. Editors are not responsible to third parties for contraventions of warranty given by the Authors. The considered rights are transferred to the editorial office since the moment when the current issue is signed for publishing. Reproduction of materials published in the Journal by other individuals and legal entities is possible only with the consent of Editorial office, with the obligatory indication of the full bibliographic reference of the primary publication. The Authors reserve the right to use the published material, its fragments and parts for teaching materials, oral presentations, dissertation thesis prepararion with obligatory bibliographic citation of the original paper. Electron copy of the published article, downloaded from official journal web-site in .pdf format may be put by authors on the official web-site of their institutions, any other official resources with open access.